⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,722.62
+0.41%
Nasdaq 100
29,577.65
+0.16%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.34
+0.12%
NYSE:TSM
$427.63
+1.76%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,125.87
−0.36%
Brent
$108.45
−0.71%
BTC
$82,658.90
+1.00%
ETH
$2,445.72
+1.68%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,722.62
+0.41%
Nasdaq 100
29,577.65
+0.16%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.34
+0.12%
NYSE:TSM
$427.63
+1.76%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,125.87
−0.36%
Brent
$108.45
−0.71%
BTC
$82,658.90
+1.00%
ETH
$2,445.72
+1.68%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
AstraZeneca PLC · News · TradingHolo
Markets
› LSE
› AZN.L
A
AstraZeneca PLC
LSE:AZN.L
Healthcare
FTSE:ASX
FTSE:NMX
£125.94
+1.56%
Delayed 15 min
In session · ≈
AED 615.79
· Market cap
$261.01B
· Next earnings
Fri 30 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
News
Profile
AZN.L news
Headlines tagged to this company
BU
Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types
BusinessWire · 19 d ago
LO
REG - AstraZeneca PLC - AZ & DS collaboration with Summit for Datroway
London Stock Exchange · 19 d ago
BU
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
BusinessWire · 19 d ago
GU
AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option
GuruFocus · 19 d ago
LO
REG - AstraZeneca PLC - Admission of Further Securities to Trading
London Stock Exchange · 19 d ago
SE
Pharmaceutical industry lobbying group names new CEO, Eric Cantor
Seeking Alpha · 20 d ago
RE
Weight-loss drug developers line up to tap lucrative market as competition heats up
Reuters · 20 d ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 20 d ago
DO
AstraZeneca Hedges Threat to Oncology Portfolio — Market Talk
Dow Jones Newswires · 20 d ago
TR
Key facts: Mid-Nov U.S. decision on ivonescimab; AstraZeneca (AZN) up
TradingView · 20 d ago
SE
AstraZeneca submits NDA for savolitinib + Tagrisso for NSCLC
Seeking Alpha · 21 d ago
GU
AstraZeneca Stock Slips as $2 Billion Summit Stake Deepens Oncology
GuruFocus · 21 d ago
GU
Summit Stock Jumps 17% on $2 Billion AstraZeneca Investment
GuruFocus · 21 d ago
DO
Fair Isaac, Carnival, Bloom Energy, SpaceX, Iovance, and More Stocks That Explain Today's Market — Barrons.com
Dow Jones Newswires · 21 d ago
RE
Pharma sector doubles down on AI to slash costs, timelines
Reuters · 21 d ago
DO
AstraZeneca Isn't Buying Summit Therapeutics. This $2 Billion Bet Might Be Even Better. — Barrons.com
Dow Jones Newswires · 21 d ago
IN
Summit Therapeutics jumps 20% after AstraZeneca’s $2 billion bet: what it signals
Invezz · 21 d ago
DO
AstraZeneca Makes Smart Move With Summit Therapeutics Deal — Market Talk
Dow Jones Newswires · 21 d ago
TR
Weekly Recap: Enhertu CHMP backing for adjuvant HER2+ and Klygefa for gMG
TradingView · 23 d ago
← Previous
End of the feed